Dr. Rupinder Singh Buttar, MD

Dr. Buttar practices at Rochester General Hospital in Rochester, New York.

Dr. Buttar's NPI, 1033665781, was assigned on August 31, 2016. Dr. Buttar holds New York license 299916.

Dr. Buttar's primary practice is Rochester General Hospital, at 1425 Portland Ave, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Buttar's primary practice is Rochester General Hospital in Rochester, New York. Dr. Buttar is also affiliated with Clifton Springs Hospital and Clinic. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Buttar to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buttar practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Buttar's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Buttar is licensed in New York.

CMS data shows 144 Medicare services from Dr. Buttar across 3 procedure codes in 2024, for 108 Medicare patients. Medicare paid $15,184 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Buttar in 2024. The largest group is 75 to 84, with 32 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buttar's median patient age at 79, with 44% women.

In 2024, Dr. Buttar wrote 153 Medicare Part D claims for 35 patients. 90% of them were for generic drugs. CMS names the drug for 44 of them, across 2 drugs with 11 or more claims each, at $335 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Buttar for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 3 papers to Dr. Buttar. The most frequent topics are Fibroblast Growth Factor-23, Phosphates and Vitamin D. Dr. Buttar's most frequent co-authors are Jasveen Batra, Maria Coco, MD and Sorab Gupta, MD.

CMS Open Payments shows 8 general payments to Dr. Buttar from 8 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $135.